⌘K

Login Start Free

Home/Filings/3/0001567619-22-001444

3//SEC Filing

DRAGSA 96 LLC 3

Accession 0001567619-22-001444

CIK 0001658551other

View on SEC.gov Company Profile

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 5:10 PM ET

Size

5.0 KB

Accession

0001567619-22-001444

Insider Transaction Report

Form 3

Period: 2022-01-11

Amylyx Pharmaceuticals, Inc.AMLX

10% Owner

Holdings

Common Stock
2,300,000

Footnotes (1)

[F1]The following persons affiliated with DRAGSA 96 LLC separately reported these securities on Form 4 filed January 13, 2022: Andreas Halvorsen, David C. Ott, Rose S. Shabet, Viking Global Investors LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, and Viking Global Opportunities Illiquid Investments Sub-Master LP.

Documents

1 file

3
doc1.xmlPrimary
FORM 3

Issuer

Amylyx Pharmaceuticals, Inc.

CIK 0001658551

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001904854

Filing Metadata

Form type: 3
Filed: Jan 20, 7:00 PM ET
Accepted: Jan 21, 5:10 PM ET
Size: 5.0 KB

View on SEC.gov